跳至主要内容
临床试验/NCT05877066
NCT05877066终止不适用

Generating Real-world Ambispective Data to Study Participant Treatment Outcomes for Dupuytren's Contracture

Endo Pharmaceuticals7 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2023年6月14日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
130
试验地点
7
主要终点
Number of Participants Receiving Each Treatment Type for DC

研究概览

简要总结

This is an observational study, meaning participants will not receive any investigational treatment as part of this study.

Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.

详细描述

Each participant of the study will have their data collected from the date of confirmed diagnosis of DC to the date of enrollment in the registry, post consent. Data will be collected from the participants clinical records as well as from the participant directly. Data will be collected through Pulse Infoframe's technology platform.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any adult with a confirmed clinical diagnosis of DC.
  • Age 18 years (or age of majority in their jurisdiction) or older at time of enrollment.
  • Willing to participate in the registry (including completion of ePROs) and complete the informed consent form.
  • Having received DC treatment, either non-surgical or surgical, within 2 weeks before enrollment, at enrollment or any time after the date of enrollment or not having received DC treatment after confirmed diagnosis of DC.
  • Able to participate in English based registry.
  • Key Exclusion criteria:
  • Not having a clinical diagnosis of DC.
  • Age less than 18 years.
  • Do not provide informed consent.

排除标准

  • 未提供

结局指标

主要结局

Number of Participants Receiving Each Treatment Type for DC

时间窗: Up to 36 months

次要结局

  • Participant Satisfaction Questionnaire(Up to 36 months)
  • Change from Baseline in Michigan Hand Questionnaire (MHQ) Scale Score(Up to 36 months)
  • Change from Baseline in European Quality of Life Five Dimension (EQ-5D) Questionnaire Score(Up to 36 months)
  • Change from Baseline in Unité Rhumatologique des Affections de la Main (URAM) Scale Score(Up to 36 months)
  • Number of Participants Receiving Post-Procedural Care by the Treating Physician(Up to 36 months)

研究者

发起方
Endo Pharmaceuticals
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验